back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-02-06 21:42 Tx date 2022-01-13 |
$PILL
Canntab Therapeutics Limited |
Fonseca, Vitor M
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$25,000
+100,000 vol $0.25 each |
400,000 | |
| Filed 2024-02-06 21:42 Tx date 2022-01-13 |
$PILL
Canntab Therapeutics Limited |
Fonseca, Vitor M
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-25,000
-100,000 vol $0.25 each |
300,000 | |
| Filed 2022-01-13 16:14 Tx date 2021-12-31 |
$PILL
Canntab Therapeutics Limited |
Fonseca, Vitor M
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$25,000
+100,000 vol $0.25 each |
||
| Filed 2022-01-13 16:07 Tx date 2021-12-31 |
$PILL
Canntab Therapeutics Limited |
Fonseca, Vitor M
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-25,000
-100,000 vol $0.25 each |
||
| Filed 2022-02-22 16:03 Tx date 2022-02-14 |
$PILL
Canntab Therapeutics Limited |
Goldstein, Richard
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+400,000 vol |
2,115,000 | |
| Filed 2022-02-22 15:59 Tx date 2022-02-14 |
$PILL
Canntab Therapeutics Limited |
Goldstein, Richard
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-100,000
-400,000 vol $0.25 each |
-250,000 | |
| Filed 2022-02-22 08:28 Tx date 2022-02-18 |
$PILL
Canntab Therapeutics Limited |
Fonseca, Vitor M
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$26,500
+106,000 vol $0.25 each |
706,000 | |
| Filed 2022-02-22 08:14 Tx date 2022-02-18 |
$PILL
Canntab Therapeutics Limited |
Fonseca, Vitor M
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$26,500
+106,000 vol $0.25 each |
600,000 | |
| Filed 2022-02-21 10:22 Tx date 2022-02-18 |
$PILL
Canntab Therapeutics Limited |
Goldstein, Richard
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
+400,000 vol |
||
| Filed 2022-02-21 10:10 Tx date 2022-02-18 |
$PILL
Canntab Therapeutics Limited |
Goldstein, Richard
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
+400,000 vol |
||
| Filed 2022-02-10 15:35 Tx date 2022-02-10 |
$PILL
Canntab Therapeutics Limited |
Goldstein, Richard
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$144,000
+200,000 vol $0.72 each |
1,715,000 | |
| Filed 2022-02-10 15:32 Tx date 2022-02-07 |
$PILL
Canntab Therapeutics Limited |
Goldstein, Richard
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$81,950
+110,000 vol $0.74 each |
1,515,000 | |
| Filed 2022-02-08 18:38 Tx date 2022-02-03 |
$PILL
Canntab Therapeutics Limited |
Fonseca, Vitor M
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$23,500
+94,000 vol $0.25 each |
234,000 | |
| Filed 2022-02-08 18:30 Tx date 2022-02-03 |
$PILL
Canntab Therapeutics Limited |
Fonseca, Vitor M
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$23,500
+94,000 vol $0.25 each |
494,000 | |
| Filed 2022-01-19 11:19 Tx date 2022-01-14 |
$PILL
Canntab Therapeutics Limited |
Goldstein, Richard
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+200,000 vol |
1,405,000 | |
| Filed 2022-01-19 11:17 Tx date 2022-01-14 |
$PILL
Canntab Therapeutics Limited |
Goldstein, Richard
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-50,000
-200,000 vol $0.25 each |
150,000 | |
| Filed 2022-01-13 16:14 Tx date 2021-12-31 |
$PILL
Canntab Therapeutics Limited |
Fonseca, Vitor M
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$25,000
+100,000 vol $0.25 each |
400,000 | |
| Filed 2022-01-13 16:07 Tx date 2021-12-31 |
$PILL
Canntab Therapeutics Limited |
Fonseca, Vitor M
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-25,000
-100,000 vol $0.25 each |
300,000 | |
| Filed 2021-10-01 17:33 Tx date 2021-10-01 |
$PILL
Canntab Therapeutics Limited |
Goldstein, Richard
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$66,310
+95,000 vol $0.70 each |
1,205,000 | |
| Filed 2021-10-01 17:26 Tx date 2021-09-29 |
$PILL
Canntab Therapeutics Limited |
Goldstein, Richard
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$28,400
+40,000 vol $0.71 each |
1,110,000 |